Skip to content
  • Sunday, 26 July 2026
  • 2:58 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Vitestro Secures $70 Million in Oversubscribed Series B to Accelerate Autonomous Phlebotomy Development and Global Commercialization
Clinical Diagnostics & Pathology

Vitestro Secures $70 Million in Oversubscribed Series B to Accelerate Autonomous Phlebotomy Development and Global Commercialization

Reynand Amr Wu Mar 29, 2026 0

Utrecht, Netherlands – Vitestro, a pioneering medical robotics company, has successfully closed an oversubscribed Series B financing round, securing an…

Read More
Clinical Diagnostics & Pathology

Vitestro Secures $70 Million to Revolutionize Blood Collection with Autonomous Robotic Phlebotomy, Poised for Global Expansion

Reynand Amr Wu Mar 22, 2026 0

Vitestro, a pioneering Dutch medical robotics company, has successfully closed an oversubscribed Series B financing round, securing an impressive $70…

Read More
Clinical Diagnostics & Pathology

Vitestro Secures $70 Million Series B Funding to Revolutionize Blood Collection with Autonomous Robotics

Reynand Amr Wu Mar 14, 2026 0

Vitestro, a pioneering Dutch medical technology firm, has successfully closed an oversubscribed Series B financing round, securing an impressive $70…

Read More
Walk-In Lab Testing Expands Patient Access and Autonomy in West VirginiaWater drops on soap bubble films act like merging galaxiesUC San Francisco Researchers Identify Biological Link Between Gut Immune Response and Brain-Mediated Appetite LossHigh Tyrosine Levels Linked to Reduced Lifespan in Men According to Comprehensive Genomic Study
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ